IS6633A - Samsetningar af fínasteríð töflum - Google Patents

Samsetningar af fínasteríð töflum

Info

Publication number: IS6633A
Authority: IS; Iceland
Prior art keywords: compositions; finasteride; tablets; finasteride tablets
Prior art date: 2002-11-22

Application number

IS6633A

Other languages

English (en)

Inventor

Johannsson Fjalar

Irnason Birkir

Original Assignee

Omega Farma Ehf.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-22

Filing date

2002-11-22

Publication date

2004-05-23

2002-11-22 Application filed by Omega Farma Ehf. filed Critical Omega Farma Ehf.

2002-11-22 Priority to IS6633A priority Critical patent/IS6633A/is

2003-11-21 Priority to US10/535,826 priority patent/US20060099251A1/en

2003-11-21 Priority to PCT/IS2003/000034 priority patent/WO2004047798A2/en

2003-11-21 Priority to EP03811862.6A priority patent/EP1575555B1/en

2003-11-21 Priority to AU2003302372A priority patent/AU2003302372A1/en

2004-05-23 Publication of IS6633A publication Critical patent/IS6633A/is

2005-06-10 Priority to IS7888A priority patent/IS2943B/is

Links

DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 title 1
229960004039 finasteride Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

IS6633A 2002-11-22 2002-11-22 Samsetningar af fínasteríð töflum IS6633A (is)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
IS6633A IS6633A (is)	2002-11-22	2002-11-22	Samsetningar af fínasteríð töflum
US10/535,826 US20060099251A1 (en)	2002-11-22	2003-11-21	Formulations of finasteride
PCT/IS2003/000034 WO2004047798A2 (en)	2002-11-22	2003-11-21	Formulations of finasteride
EP03811862.6A EP1575555B1 (en)	2002-11-22	2003-11-21	Formulations of finasteride
AU2003302372A AU2003302372A1 (en)	2002-11-22	2003-11-21	Formulations of finasteride
IS7888A IS2943B (is)	2002-11-22	2005-06-10	Fínasteríðsamsetningar

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IS6633A IS6633A (is)	2002-11-22	2002-11-22	Samsetningar af fínasteríð töflum

Publications (1)

Publication Number	Publication Date
IS6633A true IS6633A (is)	2004-05-23

Family

ID=36700777

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS6633A IS6633A (is)	2002-11-22	2002-11-22	Samsetningar af fínasteríð töflum
IS7888A IS2943B (is)	2002-11-22	2005-06-10	Fínasteríðsamsetningar

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IS7888A IS2943B (is)	2002-11-22	2005-06-10	Fínasteríðsamsetningar

Country Status (5)

Country	Link
US (1)	US20060099251A1 (is)
EP (1)	EP1575555B1 (is)
AU (1)	AU2003302372A1 (is)
IS (2)	IS6633A (is)
WO (1)	WO2004047798A2 (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ300438B6 (cs) *	2003-11-25	2009-05-20	Pliva Hrvatska D.O.O.	Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
EP2190429B1 (en) *	2007-09-10	2016-04-20	Boston Biomedical, Inc.	A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
DK2547205T3 (da)	2010-03-19	2024-05-27	1Globe Biomedical Co Ltd	Hidtil ukendte fremgangsmåder til målretning mod cancerstamceller
KR102035812B1 (ko)	2010-11-22	2019-10-23	에너지네시스 바이오메디컬 컴퍼니 리미티드	모발 성장 촉진제
EP2465581B1 (en)	2010-12-15	2020-02-05	Energenesis Biomedical Co., Ltd.	Non-therapeutic use of a composition for promoting hair growth
US20160030384A1 (en)	2013-04-09	2016-02-04	Boston Biomedical, Inc.	2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
EP3002005A1 (en)	2014-09-30	2016-04-06	Molkerei Meggle Wasserburg GmbH & Co. Kg	Direct compression excipient based on lactose, cellulose and starch
WO2018026837A1 (en) *	2016-08-02	2018-02-08	Durect Corporation	Compositions comprising oxygenated cholesterol sulfate and at least one of polyalkylene glycol, carboxymethyl cellulose and polyoxylglyceride
CA3045306A1 (en)	2016-11-29	2018-06-07	Boston Biomedical, Inc.	Naphthofuran derivatives, preparation, and methods of use thereof
JP2020520923A (ja)	2017-05-17	2020-07-16	ボストンバイオメディカル，インコーポレイテッド	がんを処置するための方法
CN108853047A (zh) *	2018-07-25	2018-11-23	江苏黄河药业股份有限公司	一种非那雄胺片及其制备方法
CN109453134A (zh) *	2018-12-03	2019-03-12	海南赛立克药业有限公司	一种含非那雄胺的药物组合物及其制备方法
GB2610163B (en) *	2021-08-12	2023-12-13	Netriver Systems Ltd	Secure online exchange of digital identification
CN122182497B (zh) *	2026-05-15	2026-08-04	浙江三生蔓迪药业有限公司	一种非那雄胺片剂的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4377584A (en) *	1978-04-13	1983-03-22	Merck & Co., Inc.	4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US6312704B1 (en) *	1993-09-30	2001-11-06	Gattefosse, S.A.	Orally administrable composition capable of providing enhanced bioavailability when ingested
US5433951A (en) *	1993-10-13	1995-07-18	Bristol-Myers Squibb Company	Sustained release formulation containing captopril and method
CA2159419C (en) *	1994-10-17	2006-07-04	Pieter De Haan	Solid pharmaceutical composition comprising an excipient capable of binding water
US5993858A (en) *	1996-06-14	1999-11-30	Port Systems L.L.C.	Method and formulation for increasing the bioavailability of poorly water-soluble drugs
GB9717444D0 (en) *	1997-08-19	1997-10-22	Glaxo Group Ltd	Pharmaceutical composition
GB9717428D0 (en) *	1997-08-19	1997-10-22	Glaxo Group Ltd	Pharmaceutical composition
DK0996429T3 (da) *	1997-10-27	2003-05-26	Merck Patent Gmbh	Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler
US6171615B1 (en) *	1998-07-06	2001-01-09	Gattefoss{acute over (e)}	Sustained release theophylline formulations, excipient systems and methods of production
US6242001B1 (en) *	1998-11-30	2001-06-05	Mcneil-Ppc, Inc.	Method for producing dispersible sterol and stanol compounds
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6294192B1 (en) *	1999-02-26	2001-09-25	Lipocine, Inc.	Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents

2002
- 2002-11-22 IS IS6633A patent/IS6633A/is unknown
2003
- 2003-11-21 US US10/535,826 patent/US20060099251A1/en not_active Abandoned
- 2003-11-21 EP EP03811862.6A patent/EP1575555B1/en not_active Expired - Lifetime
- 2003-11-21 AU AU2003302372A patent/AU2003302372A1/en not_active Abandoned
- 2003-11-21 WO PCT/IS2003/000034 patent/WO2004047798A2/en not_active Ceased
2005
- 2005-06-10 IS IS7888A patent/IS2943B/is unknown

Also Published As

Publication number	Publication date
AU2003302372A8 (en)	2004-06-18
WO2004047798A3 (en)	2004-07-29
IS2943B (is)	2016-03-15
AU2003302372A1 (en)	2004-06-18
IS7888A (is)	2005-06-10
EP1575555B1 (en)	2014-08-06
EP1575555A2 (en)	2005-09-21
US20060099251A1 (en)	2006-05-11
WO2004047798A2 (en)	2004-06-10

Publication	Publication Date	Title
DK2206517T3 (da)	2023-11-06	Immunpotentierende sammensætninger omfattende af anti-PD-L1-antistoffer
DE60310912D1 (de)	2007-02-15	Waschmittelzusammensetzungen und komponenten davon
DE60311307D1 (de)	2007-03-08	Shampoo-zusammensetzungen
ATE351898T1 (de)	2007-02-15	Feste poröse waschmittelzusammensetzungen
DE60334997D1 (de)	2010-12-30	Waschmittelzusammensetzungen
DK1575379T3 (da)	2010-09-13	Ernæringssammensætninger
DK3395338T3 (da)	2019-07-22	Hurtigt opløsende formulering af cinacalcet-hcl
ITMI20011062A0 (it)	2001-05-22	Composizioni fluoroelastomeriche
EP1534786A4 (en)	2005-10-26	COLORING COMPOSITIONS
DE10393374D2 (de)	2005-09-01	Zusammensetzung
DK1524981T3 (da)	2009-06-22	Sammensætninger med vedvarende frigivelse indeholdende lamotrigin
DK2402005T3 (da)	2021-03-15	Formuleringer med langvarig frigivelse af nalbuphin
DE60310914D1 (de)	2007-02-15	Pulverzusammensetzung
ITMI20011061A0 (it)	2001-05-22	Composizioni fluoroelastomeriche
EE200300589A (et)	2004-02-16	Ravimkoostised
DK1561472T3 (da)	2013-11-11	Faststofsammensætning
ITMI20011060A0 (it)	2001-05-22	Composizioni fluoroelastomeriche
EP1608385A4 (en)	2010-03-03	THERAPEUTIC COMPOSITIONS
NO20043937L (no)	2005-03-23	Anvendelse av vitamin D sammensetninger
DE60320902D1 (de)	2008-06-26	Zusammensetzungen mit ausgelöster Freisetzung
DE60316954D1 (de)	2007-11-29	Shampoozusammensetzungen
ITMI20011059A0 (it)	2001-05-22	Composizioni fluoroelastomeriche
SE0500163L (sv)	2005-01-24	Sammansättning
DK1337228T3 (da)	2006-03-20	Sammensætninger til fjernelse af human cerumen
AU2003302372A8 (en)	2004-06-18	Formulations of finasteride